Etrasimod AD Trial

A Phase 2 Placebo-Controlled, Dose Finding Trial to Assess the Safety and Efficacy of Etrasimod in Subjects with Moderate-to-Severe Atopic Dermatitis (also known as Eczema)

A CLINICAL STUDY FOR PEOPLE WITH MODERATE-TO-SEVERE ECZEMA.

Patients may be able to take part in the clinical program if they*:

  • Are 18-70 years of age
  • Have experienced moderate-to-severe atopic dermatitis (eczema) for at least one year
  • Have at least 10% of your body affected by eczema
  • Have had an inadequate response to topical medication

For more information please visit www.theadvisestudy.com

*Other eligibility criteria apply

For more information please visit www.theadvisestudy.com